BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen ZS, He F, Zeng FJ, Jiang JP, Du DF, Liu B. Early steroid withdrawal after liver transplantation for hepatocellular carcinoma. World J Gastroenterol 2007; 13(39): 5273-5276 [PMID: 17876900 DOI: 10.3748/wjg.v13.i39.5273]
URL: https://www.wjgnet.com/1007-9327/full/v13/i39/5273.htm
Number Citing Articles
1
Ali Zarrinpar, Fady Kaldas, Ronald W Busuttil. Liver transplantation for hepatocellular carcinoma: an updateHepatobiliary & Pancreatic Diseases International 2011; 10(3): 234 doi: 10.1016/S1499-3872(11)60039-8
2
Ju-Yeun Lee, Yul Hee Kim, Nam-Joon Yi, Hyang Sook Kim, Hye Suk Lee, Byung Koo Lee, Hyeyoung Kim, Young Rok Choi, Geun Hong, Kwang-Woong Lee, Kyung-Suk Suh. Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantationClinical and Molecular Hepatology 2014; 20(2): 192 doi: 10.3350/cmh.2014.20.2.192
3
Jan Lerut, Eliano Bonaccorsi-Riani, Patrice Finet, Pierre Gianello. Minimization of steroids in liver transplantationTransplant International 2009; 22(1): 2 doi: 10.1111/j.1432-2277.2008.00758.x
4
J.M. Kim, J.-W. Joh, S.-J. Kim, C.H.D. Kwon, S. Song, M. Shin, S.H. Hong, S.-K. Lee. Steroid Withdrawal in Adult Liver Transplantation: Occurrence at a Single CenterTransplantation Proceedings 2010; 42(10): 4132 doi: 10.1016/j.transproceed.2010.10.018
5
Cameron Fairfield, Luit Penninga, James Powell, Ewen M Harrison, Stephen J Wigmore. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patientsCochrane Database of Systematic Reviews 2015;  doi: 10.1002/14651858.CD007606.pub3
6
Quirino Lai, Samuele Iesari, Armin Finkenstedt, Maria Hoppe-Lotichius, Maxime Foguenne, Konrad Lehner, Gerd Otto, Jan Lerut. Hepatocellular carcinoma recurrence after acute liver allograft rejection treatment: A multicenter European experienceHepatobiliary & Pancreatic Diseases International 2019; 18(6): 517 doi: 10.1016/j.hbpd.2019.05.006
7
Samir Parekh, James R. Spivey. Textbook of Organ Transplantation2014; : 869 doi: 10.1002/9781118873434.ch78
8
Ali Zarrinpar, Ronald W Busuttil. Immunomodulating options for liver transplant patientsExpert Review of Clinical Immunology 2012; 8(6): 565 doi: 10.1586/eci.12.47
9
Kwang-Woong Lee, Kyung-Suk Suh. Liver Transplantation for Advanced Hepatocellular CarcinomaThe Journal of the Korean Society for Transplantation 2010; 24(1): 4 doi: 10.4285/jkstn.2010.24.1.4
10
An Bin Hu, Lin Wei Wu, Qiang Tai, Xiao Feng Zhu, Xiao Shun He. Safety and efficacy of four steroid-minimization protocols in liver transplant recipients: 3-year follow-up in a single centerJournal of Digestive Diseases 2013; 14(1): 38 doi: 10.1111/1751-2980.12008
11
L A Orci, C Toso, G Mentha, P Morel, P E Majno. Systematic review and meta-analysis of the effect of perioperative steroids on ischaemia–reperfusion injury and surgical stress response in patients undergoing liver resectionBritish Journal of Surgery 2013; 100(5): 600 doi: 10.1002/bjs.9035
12
Yuan-Yuan Liu, Chang-Ping Li, Ming-Sheng Huai, Xiao-Meng Fu, Zhuang Cui, Lin-Lin Fan, Shu Zhang, Yuan Liu, Jun Ma, Guang Li, Zhong-Yang Shen, Song Guo Zheng. Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard ImmunosuppressionPLOS ONE 2015; 10(3): e0120939 doi: 10.1371/journal.pone.0120939
13
Kan Chen, Kwan Man, Herold J. Metselaar, Harry L. A. Janssen, Maikel P. Peppelenbosch, Qiuwei Pan. Rationale of personalized immunosuppressive medication for hepatocellular carcinoma patients after liver transplantationLiver Transplantation 2014; 20(3): 261 doi: 10.1002/lt.23806
14
Cameron Fairfield, Luit Penninga, James Powell, Ewen M Harrison, Stephen J Wigmore. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patientsCochrane Database of Systematic Reviews 2018; 2018(4) doi: 10.1002/14651858.CD007606.pub4
15
Yung-Fong Tsai, Fu-Chao Liu, Chun-Yu Chen, Jr-Rung Lin, Huang-Ping Yu. Effect of Mycophenolate Mofetil Therapy on Recurrence of Hepatocellular Carcinoma after Liver Transplantation: A Population-Based Cohort StudyJournal of Clinical Medicine 2021; 10(8): 1558 doi: 10.3390/jcm10081558
16
Michael Charlton, Josh Levitsky, Bashar Aqel, John O'Grady, Julie Hemibach, Mary Rinella, John Fung, Marwan Ghabril, Ray Thomason, Patrizia Burra, Ester Coelho Little, Marina Berenguer, Abraham Shaked, James Trotter, John Roberts, Manuel Rodriguez-Davalos, Mohamed Rela, Elizabeth Pomfret, Caroline Heyrend, Juan Gallegos-Orozco, Faouzi Saliba. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant RecipientsTransplantation 2018; 102(5): 727 doi: 10.1097/TP.0000000000002147
17
Young-Kyu Kim, Kwang-Woong Lee, Seong Hoon Kim, Seong Yeon Cho, Sung-Sik Han, Sang-Jae Park. Early Steroid Withdrawal Regimen Prevents New-Onset Diabetes Mellitus in Old-Age Recipients After Living Donor Liver TransplantationWorld Journal of Surgery 2012; 36(10): 2443 doi: 10.1007/s00268-012-1661-6
18
Tonghai Xing, Li Huang, Zhenhai Yu, Lin Zhong, Shuyun Wang, Zhihai Peng, Peter Starkel. Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular CarcinomaPLoS ONE 2013; 8(8): e71251 doi: 10.1371/journal.pone.0071251
19
Jinyang Gu, Xingyu Wu, Lei Lu, Shu Zhang, Jianling Bai, Jun Wang, Jun Li, Yitao Ding. Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trialsHepatology International 2014; 8(2): 198 doi: 10.1007/s12072-014-9523-y